|Conditional recommendation based on low-quality evidence; may consider tofacitinib if the patient has contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease, or prefers oral medication.| |
|6. Switch to an IL-17i over a different OSM (PICO 25)|Low (79–87, 89–95)|